Shinsato, Y., Furukawa, T., Yunoue, S., Yonezawa, H., Minami, K., Nishizawa, Y., . . . Arita, K. (2013). Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma. Impact Journals LLC.
Chicago-стиль цитированияShinsato, Yoshinari, et al. Reduction of MLH1 and PMS2 Confers Temozolomide Resistance and Is Associated With Recurrence of Glioblastoma. Impact Journals LLC, 2013.
MLA-цитированиеShinsato, Yoshinari, et al. Reduction of MLH1 and PMS2 Confers Temozolomide Resistance and Is Associated With Recurrence of Glioblastoma. Impact Journals LLC, 2013.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.